Series A+ · BiotechCentauri Therapeutics: Series A+Develops immunotherapeutic treatments for antimicrobial infectionsPublished Oct 4, 2026By RoundOS Funding deskFunding historyFeb 24, 2026Series A+ · This round£6MSourcesbusinesswire.com↗
MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26MSeries A · Aug 27, 2026
AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120MSeries C · Aug 27, 2026
ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35MStrategic · Aug 27, 2026
ArintraAI platform automating medical coding and revenue assurance for health systems$25MSeries B · Aug 26, 2026